YELENA VANINA: Open Payments
NPI 1942250139 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,364 in 121 payments from 22 companies in 2025. Trend: 2023 $1,757 · 2024 $2,330 · 2025 $2,364
Food & beverage: $2,364
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 26 | $591 |
| Bausch Health US, LLC | 22 | $340 |
| Lundbeck LLC | 9 | $211 |
| ABBVIE INC. | 13 | $184 |
| Teva Pharmaceuticals USA, Inc. | 5 | $105 |
| Alkermes, Inc. | 6 | $103 |
| Janssen Pharmaceuticals, Inc | 4 | $96 |
| Vanda Pharmaceuticals Inc. | 4 | $87 |
| Noven Therapeutics, LLC | 5 | $84 |
| Neurocrine BioSciences, Inc. | 4 | $76 |
Products named: REXULTI, APLENZIN, ABILIFY ASIMTUFII, VRAYLAR, AUSTEDO XR, Xelstrym, INGREZZA, CAPLYTA.
Industry payments across KY — which companies pay providers there.
